Jane Street
BHVN

Jane Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Jane Street’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-68,000
Closed -$10.3M – 10960
2022
Q3 		$10.3M Sell
68,000
-15,900
-19% -$2.36M ﹤0.01% 1666
2022
Q2 		$12.2M Buy
83,900
+32,400
+63% +$4.14M 0.01% 1526
2022
Q1 		$6.11M Buy
51,500
+28,800
+127% +$3.59M ﹤0.01% 2703
2021
Q4 		$3.13M Buy
22,700
+18,400
+428% +$2.34M ﹤0.01% 3615
2021
Q3 		$597K Buy
+4,300
New +$537K ﹤0.01% 6949
2021
Q1 		– Sell
-84,600
Closed -$7.25M – 10040
2020
Q4 		$7.25M Buy
84,600
+80,400
+1,914% +$6.81M ﹤0.01% 1711
2020
Q3 		$273K Sell
4,200
-9,700
-70% -$636K ﹤0.01% 6026
2020
Q2 		$1.02M Buy
+13,900
New +$740K ﹤0.01% 4043
2020
Q1 		– Sell
-4,600
Closed -$250K – 6470
2019
Q4 		$250K Buy
+4,600
New +$228K ﹤0.01% 4503

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Jane Street's BHVN Position: Q4 2022 in Review

Jane Street sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 30,716 shares — an estimated $4.64M sold.

Jane Street first reported a position in BHVN in Q1 2018 and held it in 17 quarters. The position peaked at $8.4M in Q2 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Jane Street reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 30,716 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.64M.
  • Jane Street first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 17 quarters.
  • Jane Street's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8.4M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.